Andre Pelegrin
Inserm, 208 Rue Des Apothicaires, 34298 Montpellier CEDEX 5
Montpellier, 34298, France
Montpellier, 34298, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Correction: The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation.
Journal: Oncotarget
Published: October 11, 2024
Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer.
Journal: Frontiers in immunology
Published: February 17, 2023
Carcinoembryonic Antigen-Related Cell Adhesion Molecule Type 5 Receptor-Targeted Fluorescent Intraoperative Molecular Imaging Tracer for Lung Cancer: A Nonrandomized Controlled Trial.
Journal: JAMA network open
Published: January 27, 2023
Improving Patients' Life Quality after Radiotherapy Treatment by Predicting Late Toxicities.
Journal: Cancers
Published: February 24, 2022
Glycoprotein Receptor CEACAM5-Targeted Intraoperative Molecular Imaging Tracer in Non-Small Cell Lung Cancer.
Journal: The Annals of thoracic surgery
Published: February 12, 2022
Improving Biologics' Effectiveness in Clinical Oncology: From the Combination of Two Monoclonal Antibodies to Oligoclonal Antibody Mixtures.
Journal: Cancers
Published: July 08, 2021
Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival.
Journal: International journal of oncology
Published: October 12, 2020
Multimodal CEA-Targeted Image-Guided Colorectal Cancer Surgery using 111In-Labeled SGM-101.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 11, 2020
Last Updated: 09/26/2026